Sexuality after hematopoietic stem cell transplantation

Area of Science:

• Oncology
• Reproductive Medicine
• Hematology

Background:

• High-dose chemotherapy and hematopoietic stem cell transplantation (HSCT) can lead to significant long-term gonadal dysfunction in survivors.
• This dysfunction manifests as hormonal imbalances affecting sexual desire, genital health, and overall sexual activity.
• Sexual dysfunction is a prevalent and persistent issue among HSCT survivors, impacting quality of life.

Purpose of the Study:

• To assess the prevalence and nature of sexual dysfunction in long-term survivors of HSCT.
• To understand the impact of HSCT on male and female sexual functioning using a validated questionnaire.
• To identify the need for effective interventions for sexual dysfunction in this population.

Main Methods:

• Utilized the Sexual Functioning Questionnaire (SFQ), specifically designed and validated for the HSCT population.
• Compared sexual functioning data from HSCT survivors with age- and gender-matched healthy controls.
• Analyzed reported sexual desire, genital organ function, sexual response quality, and sexual behaviors.

Main Results:

• HSCT survivors report significantly higher rates of sexual dysfunction compared to healthy controls.
• Sexual dysfunction issues are more pronounced and prevalent in female survivors than in male survivors.
• Problems related to sexual function persist over time if not addressed early, highlighting the need for timely management.

Conclusions:

• Sexual dysfunction is a common and serious long-term consequence of HSCT, significantly affecting survivor well-being.
• While evidence for current interventions is limited, promising medical and behavioral treatments warrant further investigation.
• Early detection and proactive management are essential to mitigate the long-term impact of sexual dysfunction in HSCT survivors.